Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2008 2
2009 3
2010 5
2011 3
2012 3
2013 1
2014 3
2015 1
2016 5
2017 2
2018 1
2019 4
2020 6
2021 4
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Origin and Therapies of Osteosarcoma.
Moukengue B, Lallier M, Marchandet L, Baud'huin M, Verrecchia F, Ory B, Lamoureux F. Moukengue B, et al. Among authors: baud huin m. Cancers (Basel). 2022 Jul 19;14(14):3503. doi: 10.3390/cancers14143503. Cancers (Basel). 2022. PMID: 35884563 Free PMC article. Review.
Ribosomopathies: New Therapeutic Perspectives.
Orgebin E, Lamoureux F, Isidor B, Charrier C, Ory B, Lézot F, Baud'huin M. Orgebin E, et al. Among authors: baud huin m. Cells. 2020 Sep 11;9(9):2080. doi: 10.3390/cells9092080. Cells. 2020. PMID: 32932838 Free PMC article. Review.
BET bromodomains' functions in bone-related pathologies.
Jacques C, Lavaud M, Georges S, Tesfaye R, Baud'huin M, Lamoureux F, Ory B. Jacques C, et al. Among authors: baud huin m. Epigenomics. 2020 Jan;12(2):127-144. doi: 10.2217/epi-2019-0172. Epub 2019 Dec 18. Epigenomics. 2020. PMID: 31849242 Review.
Ewing sarcoma from molecular biology to the clinic.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baud'huin M, Georges S, Brounais-Le Royer B, Ory B, Rédini F, Verrecchia F. Dupuy M, et al. Among authors: baud huin m. Front Cell Dev Biol. 2023 Sep 11;11:1248753. doi: 10.3389/fcell.2023.1248753. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37752913 Free PMC article. Review.
Proteoglycans and osteolysis.
Baud'Huin M, Charrier C, Bougras G, Brion R, Lezot F, Padrines M, Heymann D. Baud'Huin M, et al. Methods Mol Biol. 2012;836:323-37. doi: 10.1007/978-1-61779-498-8_21. Methods Mol Biol. 2012. PMID: 22252644 Free PMC article.
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
Marchandet L, Lallier M, Charrier C, Baud'huin M, Ory B, Lamoureux F. Marchandet L, et al. Among authors: baud huin m. Cancers (Basel). 2021 Feb 8;13(4):683. doi: 10.3390/cancers13040683. Cancers (Basel). 2021. PMID: 33567616 Free PMC article. Review.
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
Lallier M, Marchandet L, Moukengue B, Charrier C, Baud'huin M, Verrecchia F, Ory B, Lamoureux F. Lallier M, et al. Among authors: baud huin m. Cells. 2021 Mar 30;10(4):754. doi: 10.3390/cells10040754. Cells. 2021. PMID: 33808130 Free PMC article. Review.
Osteoprotegerin: multiple partners for multiple functions.
Baud'huin M, Duplomb L, Teletchea S, Lamoureux F, Ruiz-Velasco C, Maillasson M, Redini F, Heymann MF, Heymann D. Baud'huin M, et al. Cytokine Growth Factor Rev. 2013 Oct;24(5):401-9. doi: 10.1016/j.cytogfr.2013.06.001. Epub 2013 Jul 1. Cytokine Growth Factor Rev. 2013. PMID: 23827649 Free article. Review.
Super-enhancers: drivers of cells' identities and cells' debacles.
Lavaud M, Tesfaye R, Lassous L, Brounais B, Baud'huin M, Verrecchia F, Lamoureux F, Georges S, Ory B. Lavaud M, et al. Among authors: baud huin m. Epigenomics. 2024 Apr 8. doi: 10.2217/epi-2023-0409. Online ahead of print. Epigenomics. 2024. PMID: 38587919 Review.
47 results